AstraZeneca ditches £450m investment in UK plant - BBC
6 days ago · AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Merseyside, blaming a reduction in government support. The pharmaceutical giant announced its decision ...
'AstraZeneca ditches vaccine plant' and Trump's EU tariff threat
5 days ago · The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, calling it "a blow to the government's growth agenda". The paper says ...
AstraZeneca scraps plan to expand vaccine plant in the UK in …
6 days ago · LONDON (AP) — Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a vaccine manufacturing plant in northwest England, blaming the new Labour government for diluting the financial support that had been offered by the previous Conservative administration.
AstraZeneca abandons £450m vaccine factory in blow to Reeves
6 days ago · AstraZeneca has abandoned a £450m investment in a major UK vaccine plant just days after Rachel Reeves vowed to “kick-start economic growth”.. The drugmaker, which is Britain’s most ...
'AstraZeneca ditches vaccine plant' and Trump's EU tariff threat
5 days ago · The Financial Times, external leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, calling it "a blow to the government's growth agenda". The paper ...
AstraZeneca expands US manufacturing footprint to accelerate …
Feb 6, 2024 · AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for critical cancer trials and future commercial supply.
AstraZeneca plans $1.5 billion manufacturing facility for antibody …
May 20, 2024 · AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC portfolio. ADCs are next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody.
AstraZeneca expands US manufacturing footprint to accelerate …
WILMINGTON, Del., February 06, 2024 -- (BUSINESS WIRE)--AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in...
AstraZeneca reveals plans for a billion-dollar cancer plant in ...
May 20, 2024 · Pharmaceutical giant AstraZeneca is to open a $1.5 billion (€1.38 billion) cancer manufacturing plant in Singapore, as part of a plan to develop and strengthen its presence around the world.
AstraZeneca to build $1.5-bln cancer drug plant in Singapore
May 20, 2024 · AstraZeneca plans to build a $1.5 billion manufacturing facility in Singapore to produce a promising category of cancer-killing drugs called antibody-drug conjugates (ADCs), the Anglo-Swedish...